ClinicalTrials.Veeva

Menu

The Added Value of Bone Microstructure Assessment in the Management of Osteoporotic Bone (ADVANTAGE BONE)

R

Robert Jones and Agnes Hunt Orthopaedic and District NHS Trust

Status

Not yet enrolling

Conditions

Osteoporosis

Treatments

Other: Trabecular bone score software

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

  1. To assess the clinical utility of trabecular bone score (TBS) on fracture risk prediction including the new version (TBS V4) and future TBS versions at the spine and hip.
  2. To assess the clinical utility of TBS software as a potential treatment outcome: sensitivity to change over time and following osteoporosis therapy.
  3. To compare TBS to other imaging modalities of bone structure such as quantitative computed tomography (QCT) in fracture risk prediction and response to osteoporosis therapy.

Enrollment

1,500 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria: Has had a DEXA scan

  • Has had a DEXA scan

Exclusion Criteria:

  • Unable to complete DEXA scan

Trial contacts and locations

0

Loading...

Central trial contact

Claire Mennan, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems